Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Haematologica（2020）
关键词
Bone Marrow Failure,Eltrombopag,Lower risk myelodysplastic syndrome,Myelodysplastic Syndromes,Thrombopoetin agonist
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要